Herbalife Nutrition cuts Q3/FY2021 guidance; net sales growth midpoint lowered 400 bps

HERBALIFE LTD.

Q3 net sales expected down 3.5%-6.5% vs 2020; prior midpoint lowered 700 bps.
FY 2021 net sales growth revised to 4.5%-8.5% vs 2020 (midpoint down 400 bps).
Adjusted diluted EPS guidance: Q3 $1.00-$1.20; FY $4.55-$4.95 (midpoint -$0.15).
Adjusted EBITDA guidance: Q3 $200-$220M; FY $860-$910M (prior $875-$935M).
Company plans >$200M share repurchase in H2; active sales leaders up 10% vs 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.